Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Baupost Doubled its Bet on Aveo Pharmaceuticals $AVEO

Seth Klarman isn’t very bullish about the stock market. Klarman just disclosed that he reduced his BBEP holdings by $40 Million. He is concerned about runaway inflation and currency collapse. Here is what he said in his latest investor letter:


“…Disaster hedging – always an important tool for investors – takes on heightened significance in today’s unprecedentedly challenging environment. Yet, as this insight is not unique to us, the cost of insurance is high. There are no easy ways to navigate these turbulent waters. But because the greatest risks are of currency debasement and runaway inflation, protection against a currency collapse – such as exposure to gold – and against much higher interest rates seem like necessary hedges to maintain.”

We guess drugs might provide some protection against inflation as well. Baupost doubled its bet on Aveo Pharma (AVEO) at the end of April. Today Baupost disclosed that it now owns 4.2 Million shares of AVEO. At the end of December Klarman had only 2 Million shares.

Samuel Isaly’s OrbiMed Advisors had nearly 1 Million shares of AVEO at the end of December. Brookside Capital had nearly 900 thousand shares and Anand Parekh’s Alyeska Investment Group had nearly 600 K AVEO shares in their portfolios. Aveo increased 4.9% today.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!